The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits offered as efficient and economical […]readmore
Tags : Companies
Shots: Jenburkt became the second company to launch Favivent (favipiravir) to treat mild to moderate COVID-19 symptoms at a price of Rs. 39/tablet Cipla receives the DCGI approval for Ciplenza […]readmore
With the era of growing diseases, Diagnostics have played a vital role in diagnosing multiple diseases and disorders. The healthcare system is changing, with a greater focus on value, reducing […]readmore
The Medical device market is growing with greater needs of patients and with their emerging diseases. 2018 has shown major advancement in medical device needs and upgrades with 55 novel […]readmore
The Pharma companies focusing on oncology has been emerging in market with greater needs of people suffering from Cancer. The sales of oncology drugs gradually increasing with diseases. The top […]readmore
Shots: Verily enters into a collaboration with Novartis, Otsuka, Pfizer and Sanofi for the development of technology-enabled, patient-centered clinical research programs utilizing Verily’s Project Baseline Platform The focus of the […]readmore
Top 20 BioPharma Companies based on 2018 Total Revenue The global pharma companies have been advancing their pipelines with emerging needs of patients. Pharma companies are also focusing on diagnostics […]readmore
Shots: In Oct, 2018 Pfizer appointed Dr. Albert Bourla as its new CEO, successor of Lan C. Read (7 Dec, 2010 – 31 Dec, 2018) In Feb, 2018 Novartis appointed […]readmore